Patient decision-making and clinical outcomes following endoscopic therapy or esophagectomy for Barrett’s neoplasia

Abstract

Background and study aims The objective of this study was to assess patient involvement in decision-making, decision confidence, and decision regret among patients who had undergone endoscopic eradication therapy (EET) or esophagectomy for Barrett’s esophagus (BE) associated neoplasia.

Patients and methods Patients with BE high grade dysplasia or intramucosal (T1a) adenocarcinoma who had undergone EET or esophagectomy were invited to complete a survey.

Results The cohort included 50 subjects, 70 % (35/50) of whom had undergone EET and 30 % (15/50) of whom had undergone esophagectomy. Subjects who underwent esophagectomy were more likely to report post-treatment dysphagia (47 % vs 14 %, P = 0.03), post-treatment dietary modification (73 % vs 6 %, P < 0.0001), and were less likely to view their post-treatment health favorably. However, when asked whether they had selected the right treatment, a high degree of confidence was reported by both groups (mean 9.8 for EET vs 9.3 for esophagectomy on a 0 – 10 scale, P = 0.12). In fact, 97 % (34/35) of EET patients and 80 % (12/15) of esophagectomy patients indicated they would select the same treatment option (P = 0.08).

Conclusions Patients who have undergone EET or surgery for BE neoplasia report a high degree of involvement in the decision-making process. Although EET patients report fewer symptom-specific outcomes, measures of decision confidence and decision regret do not differ between the two treatment groups.

• References

• 1 Pech O, May A, Manner H. et al. Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology 2014; 146: 652-660 e651 (doi:10.1053/j.gastro.2013.11.006)
• 2 Ngamruengphong S, Wolfsen HC, Wallace MB. Survival of patients with superficial esophageal adenocarcinoma following endoscopic treatment vs surgery. Clin Gastroenterol Hepatol 2013; 11: 1424-e1481 (doi:10.1016/j.cgh.2013.05.025)
• 3 Naik AD, Dyer CB, Kunik ME. et al. Patient autonomy for the management of chronic conditions: a two-component re-conceptualization. Am J Bioethics 2009; 9: 23-30 (doi:10.1080/15265160802654111)
• 4 American Gastroenterological Association. Spechler SJ, Sharma P. et al. American Gastroenterological Association medical position statement on the management of Barrett’s esophagus. Gastroenterology 2011; 140: 1084-1091
• 5 Baker SK, Mayer DK, Esposito N. The contralateral prophylactic mastectomy decision-making process. Plast Surg Nurs 2013; 33: 11-21; quiz 22-13 (doi:10.1097/PSN.0b013e3182842424)
• 6 Lee CN, Chang Y, Adimorah N. et al. Decision making about surgery for early-stage breast cancer. J Am Coll Surg 2012; 214: 1-10 (doi:10.1016/j.jamcollsurg.2011.09.017)
• 7 Sepucha KR, Belkora JK, Chang Y. et al. Measuring decision quality: psychometric evaluation of a new instrument for breast cancer surgery. BMC Med Inform Decis Mak 2012; 12: 51 (doi:10.1186/1472-6947-12-51)
• 8 Yachimski P, Nishioka NS, Richards E. et al. Treatment of Barrett’s esophagus with high-grade dysplasia or cancer: predictors of surgical versus endoscopic therapy. Clin Gastroenterol Hepatol 2008; 6: 1206-1211 (doi:10.1016/j.cgh.2008.04.031)
• 9 Rosmolen WD, Boer KR, de Leeuw RJ. et al. Quality of life and fear of cancer recurrence after endoscopic and surgical treatment for early neoplasia in Barrett’s esophagus. Endoscopy 2010; 42: 525-531 (doi:10.1055/s-0029-1244222)
• 10 Diefenbach MA, Mohamed NE. Regret of treatment decision and its association with disease-specific quality of life following prostate cancer treatment. Cancer Invest 2007; 25: 449-457 (doi:10.1080/07357900701359460)
• 11 Festinger L. A theory of cognitive dissonance. Stanford University Press; 1962